Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 57281 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 2:45 p.m. to 3 

p.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Open: October 18, 2010, 3:15 p.m. to 4:30 

p.m. 

Agenda: Scientific Presentations. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 4:30 p.m. to 5:30 

p.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 7:30 p.m. to 

Adjournment. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Doubletree Guest Suites, 2515 

Meridian Parkway, Research Triangle Park, 

NC 27713. 

Closed: October 19, 2010, 8:30 a.m. to 10 

a.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Contact Person: William T Schrader, PhD, 

Deputy Scientific Director, Office of the 

Scientific Director, National Institute of 

Environmental Health Sciences, 111 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (919) 541–3433, 

schrader@niehs.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: September 9, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23382 Filed 9–17–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 11 a.m.–2 p.m., October 7, 

2010. 

Place: Audio Conference Call via FTS 

Conferencing. The USA toll-free, dial-in 

number is 1(866) 659–0537 and the pass code 

is 9933701. 

Status: Open to the public, but without a 

public comment period. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, which 

have been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to the 

CDC. NIOSH implements this responsibility 

for CDC. The charter was issued on August 

3, 2001, renewed at appropriate intervals and 

will expire on August 3, 2011. 

Purpose: This Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. 

Matters to be Discussed: The agenda for the 

conference call includes: NIOSH 10-Year 

Review of its Division of Compensation 

Analysis and Support (DCAS) Program; 

Review of Public Comments to the Advisory 

Board during May 2010 Meeting; Status of 

DOL Policy Issuance on Use of Ruttenber 

Data; Coordinating DCAS Support of Board 

Activities; Advisory Board Subcommittee 

and Work Group Updates; and, DCAS SEC 

Petition Evaluations Update for the 

November 2010 Advisory Board Meeting. 

The agenda is subject to change as 

priorities dictate. 

Because there is not a public comment 

period, written comments may be submitted. 

Any written comments received will be 

included in the official record of the meeting 

and should be submitted to the contact 

person below in advance of the meeting. 

Contact Person for More Information: 

Theodore M. Katz, M.P.A., Executive 

Secretary, NIOSH, CDC, 1600 Clifton Road 

NE., Mailstop: E–20, Atlanta, GA 30333, 

Telephone (513) 533–6800, Toll Free 1(800) 

CDC–INFO, E-mail ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–23378 Filed 9–17–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary delisting 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS 

ACTION: Notice of Delisting. 

SUMMARY: AHRQ has accepted a 

notification of voluntary relinquishment 

from the Florida Patient Safety 

Corporation of its status as a Patient 

Safety Organization (PSO). The Patient 

Safety and Quality Improvement Act of 

2005 (Patient Safety Act), Public Law 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 


jdjones on DSK8KYBLC1PROD with NOTICES
57282 Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 

delivery. The Patient Safety and Quality 

Improvement Final Rule (Patient Safety 

Rule), 42 CFR Part 3, authorizes AHRQ, 

on behalf of the Secretary of HHS, to list 

as a PSO an entity that attests that it 

meets the statutory and regulatory 

requirements for listing. A PSO can be 

‘‘delisted’’ by the Secretary if it is found 

to no longer meet the requirements of 

the Patient Safety Act and Patient Safety 

Rule, including when a PSO chooses to 

voluntarily relinquish its status as a 

PSO for any reason. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12 Midnight 

ET (2400) on April 1, 2010. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Diane Cousins, RPh., Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; E-mail: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule (PDF file, 450 KB. PDF Help) 

relating to the listing and operation of 

PSOs. Section 3108(d) of the Patient 

Safety Rule requires AHRQ to provide 

public notice when it removes a PSO 

from listing. AHRQ has accepted a 

notification from the Florida Patient 

Safety Corporation, PSO number P0001, 

to voluntarily relinquish its status as a 

PSO. Accordingly, the Florida Patient 

Safety Corporation was delisted 

effective at 12 Midnight ET (2400) on 

April 1, 2010. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: September 3, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–23078 Filed 9–17–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Organization, Functions 

and Delegations of Authority 

This notice amends Part R of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Health Resources and 

Services Administration (HRSA) (60 FR 

56605, as amended November 6, 1995; 

as last amended at 75 FR 51088–51091 

dated August 18, 2010). 

This notice reflects organizational 

changes in the Health Resources and 

Services Administration. This notice 

updates the functional statement for the 

Office of Special Health Affairs (RA1) 

and the functional statement for the 

Office of Planning, Analysis and 

Evaluation (RA5). Specifically, this 

notice moves the Office of Health 

Information Technology and Quality 

(RA52) from the Office of Planning, 

Analysis and Evaluation (RA5) to the 

Office of Special Health Affairs (RA1); 

abolishes the Office of Data 

Management and Research (RA54) and 

establishes the Office of Research and 

Evaluation (RA56); and eliminates the 

Office of Planning and Evaluation 

(RA51) and moves its functions to the 

Office of Research and Evaluation 

(RA56). 

Chapter RA1—Office of Special Health 

Affairs 

Section RA1–10, Organization 

Delete in its entirety and replace with 

the following: 

The Office is headed by the Director, 

Office of Special Health Affairs (RA1), 

who reports directly to the 

Administrator, Health Resources and 

Services Administration. Office of 

Special Health Affairs includes the 

following components: 

(1) Office of the Director (RA1); 

(2) Office of Health Equity (RA11); 

(3) Office of Global Health Affairs 

(RA12); 

(4) Office of Strategic Priorities 

(RA13); and 

(5) Office of Health Information 

Technology and Quality (RA14). 

Section RA1–20, Functions 

(1) Delete the functional statement for 

the Office of the Director (RA1) and 

replace in its entirety; and (2) establish 

the Office of Health Information 

Technology and Quality (RA14). 

Office of the Director (RA1) 

Provides overall leadership, direction, 

coordination, and planning in the 

support of the Agency’s special health 

programs. Specifically: (1) Plans and 

directs activities to advance health 

equity and improve minority health and 

eliminate health disparities; (2) 

develops strategies to maximize HRSA’s 

participation in efforts to improve 

health care for vulnerable populations 

worldwide; (3) provides leadership and 

direction to improve the delivery and 

quality of oral health care, mental health 

and other priority health concerns; (4) 

provides leadership in the development 

of policies on health information 

technology and quality; and (5) provides 

support for the Department’s Medical 

Claims Review Panel. 

Office of Health Information 

Technology and Quality (RA14) 

Serves as the principal advisor and 

coordinator to the Agency for health 

information technology and quality. 

Specifically: (1) Provides support, 

policy direction, and leadership for 

HRSA’s health quality efforts; (2) serves 

as the focal point for developing policy 

to promote the coordination and 

advancement of health information 

technology, including telehealth, to 

HRSA’s programs, including the use of 

electronic health record systems; (3) 

develops an Agency-wide health 

information technology and telehealth 

strategy for HRSA; (4) assists HRSA 

components in program-level health 

information technology and health 

quality efforts; (5) ensures successful 

dissemination of appropriate 

information technology advances, such 

as electronic health records systems, to 

HRSA programs; (6) works 

collaboratively with States, foundations, 

national organizations, private sector 

providers, as well as departmental 

agencies and other Federal departments 

in order to promote the adoption of 

health information technology and 

health quality policy; (7) ensures the 

health information technology policy 

and activities of HRSA are coordinated 

with those of other HHS components; 

(8) assesses the impact of health 

information technology and quality 

initiatives in the community, especially 

for the uninsured, underserved, and 

special needs populations; (9) translates 

technological advances in health 

information technology to HRSA’s 

programs; (10) provides guidance in 

using the results of the medical claims 

review process to HRSA programs to 

improve quality; and (11) provides 

support for the Department’s Medical 

Claims Review Panel. 


jdjones on DSK8KYBLC1PROD with NOTICES